Ellen M. Haugsten
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
A rhabdomyosarcoma cell migration inhibitor screen using phase-contrast microscopy.
Journal: Experimental cell research
Published: April 11, 2025
Automated tracking of cell migration in phase contrast images with CellTraxx.
Journal: Scientific reports
Published: July 13, 2023
Strategies to inhibit FGFR4 V550L-driven rhabdomyosarcoma.
Journal: British journal of cancer
Published: February 22, 2022
Fibroblast Growth Factor 2 Conjugated with Monomethyl Auristatin E Inhibits Tumor Growth in a Mouse Model.
Journal: Biomacromolecules
Published: September 20, 2021
Roles of the FGF-FGFR Signaling System in Cancer Development and Inflammation.
Journal: Cells
Published: August 21, 2021
ALFY localizes to early endosomes and cellular protrusions to facilitate directional cell migration.
ALFY localizes to early endosomes and cellular protrusions to facilitate directional cell migration.
Journal: Journal of cell science
Published: July 15, 2021
Negative Regulation of FGFR (Fibroblast Growth Factor Receptor) Signaling.
Journal: Cells
Published: April 29, 2021
Cancer Mutations in FGFR2 Prevent a Negative Feedback Loop Mediated by the ERK1/2 Pathway.
Journal: Cells
Published: April 17, 2019
Crosstalk between p38 and Erk 1/2 in Downregulation of FGF1-Induced Signaling.
Journal: International journal of molecular sciences
Published: January 14, 2019
Last Updated: 09/26/2026